OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
R. Christian Moreton, PhD, is vice-president of pharmaceutical sciences at Finnbrit Consulting and a member of Pharmaceutical Technology’s editorial advisory board.
February 03, 2021
Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
April 02, 2020
With ingredients sold to multiple markets, excipient manufacturers must understand the different regulatory requirements for pharma vs. food.
October 01, 2019
This article seeks to encourage continued dialogue among stakeholders to achieve consensus regarding excipient additives and processing aids.
October 02, 2017
This article seeks to promote dialogue among stakeholders to facilitate consensus regarding requirements for excipients.
May 02, 2016
As the pharmaceutical industry moves toward continuous manufacturing, new documents are needed to provide flexible guidance that meets the new process requirements.
October 02, 2007
Change is inevitable, as is contract manufacturing. But which companies will survive the drifts?